1. Home
  2. SVCO vs GOSS Comparison

SVCO vs GOSS Comparison

Compare SVCO & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVCO
  • GOSS
  • Stock Information
  • Founded
  • SVCO 1984
  • GOSS 2015
  • Country
  • SVCO United States
  • GOSS United States
  • Employees
  • SVCO N/A
  • GOSS N/A
  • Industry
  • SVCO
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVCO
  • GOSS Health Care
  • Exchange
  • SVCO NYSE
  • GOSS Nasdaq
  • Market Cap
  • SVCO 221.9M
  • GOSS 212.9M
  • IPO Year
  • SVCO 2024
  • GOSS 2019
  • Fundamental
  • Price
  • SVCO $7.87
  • GOSS $0.81
  • Analyst Decision
  • SVCO Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • SVCO 6
  • GOSS 5
  • Target Price
  • SVCO $20.83
  • GOSS $9.20
  • AVG Volume (30 Days)
  • SVCO 241.5K
  • GOSS 2.3M
  • Earning Date
  • SVCO 02-14-2025
  • GOSS 11-07-2024
  • Dividend Yield
  • SVCO N/A
  • GOSS N/A
  • EPS Growth
  • SVCO N/A
  • GOSS N/A
  • EPS
  • SVCO N/A
  • GOSS N/A
  • Revenue
  • SVCO $54,307,000.00
  • GOSS $105,322,000.00
  • Revenue This Year
  • SVCO $15.49
  • GOSS N/A
  • Revenue Next Year
  • SVCO $17.07
  • GOSS N/A
  • P/E Ratio
  • SVCO N/A
  • GOSS N/A
  • Revenue Growth
  • SVCO 5.33
  • GOSS N/A
  • 52 Week Low
  • SVCO $6.14
  • GOSS $0.50
  • 52 Week High
  • SVCO $21.59
  • GOSS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • SVCO N/A
  • GOSS 49.87
  • Support Level
  • SVCO N/A
  • GOSS $0.76
  • Resistance Level
  • SVCO N/A
  • GOSS $0.88
  • Average True Range (ATR)
  • SVCO 0.00
  • GOSS 0.08
  • MACD
  • SVCO 0.00
  • GOSS 0.01
  • Stochastic Oscillator
  • SVCO 0.00
  • GOSS 30.48

About SVCO SILVACO GROUP INC

Silvaco Group Inc is a provider of technology computer aided design ("TCAD") software, electronic data automation ("EDA") software and semiconductor intellectual property ("SIP"). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the "technology behind the chip" and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: